Skip to main content
Download PDF
  • Research article
  • Open access
  • Published:

Clinical updates of approaches for biopsy of pulmonary lesions based on systematic review

BMC Pulmonary Medicine volume 18, Article number: 146 (2018) Cite this article

Abstract

Background

Convenient approaches for accurate biopsy are extremely important to the diagnosis of lung cancer. We aimed to systematically review the clinical updates and development trends of approaches for biopsy, i.e., CT-guided PTNB (Percutaneous Transthoracic Needle Biopsy), ENB (Electromagnetic Navigation Bronchoscopy), EBUS-TBNA (Endobroncheal Ultrasonography-Transbronchial Needle Aspiration), mediastinoscopy and CTC (Circulating Tumor Cell).

Methods

Medline and manual searches were performed. We identified the relevant studies, assessed study eligibility, evaluated methodological quality, and summarized diagnostic yields and complications regarding CT-guided PTNB (22 citations), ENB(31 citations), EBUS-TBNA(66 citations), Mediastinoscopy(15 citations) and CTC (19 citations), respectively.

Results

The overall sensitivity and specificity of CT-guided PTNB were reported to be 92.52% ± 3.14% and 97.98% ± 3.28%, respectively. The top two complications of CT-guided PTNB was pneumothorax (946/4170:22.69%) and hemorrhage (138/1949:7.08%). The detection rate of lung cancer by ENB increased gradually to 79.79% ± 15.34% with pneumothorax as the top one complication (86/1648:5.2%). Detection rate of EBUS-TBNA was 86.06% ± 9.70% with the top three complications, i.e., hemorrhage (53/8662:0.61%), pneumothorax (46/12432:0.37%) and infection (34/11250:0.30%). The detection rate of mediastinoscopy gradually increased to 92.77% ± 3.99% with .hoarseness as the refractory complication (4/2137:0.19%). Sensitivity and specificity of CTCs detection by using PCR (Polymerase Chain Reaction) were reported to be 78.81% ± 14.72% and 90.88% ± 0.53%, respectively.

Conclusion

The biopsy approaches should be chosen considering a variety of location and situation of lesions. CT-guided PTNB is effective to reach lung parenchyma, however, diagnostic accuracy and incidence of complications may be impacted by lesion size or needle path length. ENB has an advantage for biopsy of smaller and deeper lesions in lung parenchyma. ENB plus EBUS imaging can further improve the detection rate of lesion in lung parenchyma. EBUS-TBNA is relatively safer and mediastinoscopy provides more tissue acquisition and better diagnostic yield of 4R and 7th lymph node. CTC detection can be considered for adjuvant diagnosis.

Peer Review reports

Background

Lung cancer is the most frequently diagnosed cancer and continues to be the leading cause of cancer mortality among both males and females [1]. The 5-year survival rate of lung cancer is only 18%, largely due to late-stage diagnosis [1]. Thus, early diagnosis is especially critical to improve long-term survival. Biopsy is important for identification and confirmation of lung cancer. In clinical practice, conventional flexible bronchoscopy is supposed to be difficult for biopsy of small lesions in lung parenchyma or mediastinum. Therefore, we focused on the following approaches for biopsy according to a variety of lesion location in lung parenchyma, i.e., CT-guided PTNB(Percutaneous Transthoracic Needle Biopsy), ENB (Electromagnetic Navigation Bronchoscopy), EBUS-TBNA (Endobroncheal Ultrasonography-Transbronchial Needle Aspitation) and mediastinoscopy. Furthermore, the studies regarding liquid biopsies, e.g., CTC (Circulating Tumor Cell) detection are timely and hot, and warrant to be systematically reviewed.

Therefore, we evaluated the published studies in the last 20 years which focused on CT-guided PTNB, ENB, EBUS-TBNA, mediastinoscopy and CTC, aiming to reveal the clinical updates, development trends, detection rates and complications.

Methods

We used systematic review to identify relevant studies, assess study eligibility, evaluate methodological quality, and summarize findings regarding postoperative clinical outcomes. Medline and manual searches were performed by investigators CJD and FQD independently and jointly to identify all published articles in English journals from January 1, 2000 to November 9, 2017 that addressed the issues regarding detection of lung cancers by using CT-guided PTNB, ENB, EBUS-TBNA, mediastinoscopy and CTCs, respectively. The Medline search was done on PubMed (http://www.ncbi.nlm.nih.gov). The search strategies and yielded citations were shown in Tables 1 and 2, respectively. Investigators CJD and FQD performed the actual search and data abstraction.

Table 1 Data sources and searches regarding Clinical updates of approaches for biopsy
Full size table
Table 2 Information of yielded citations regarding approaches for biopsy
Full size table

Data abstraction

From the eligible articles, investigators CJD and FQD reviewed the following information, i.e., PMID, year of publication, study design, number of patients, average age of patients, nodules size and location, operation time, biomarkers for detection, diagnostic sensitivity, relative complication morbidity, treatment of complications, outcome and follow-up period.

Statistical analysis

The association between detection rate of ENB and nodule size, number of cases, operation time, average age of patients, sex, and mean distance of the lesions from the pleura was performed using Pearson’s correlation analysis. The impact of nodule location on detection rate of ENB was analyzed by using ANOVA analysis. The association between morbidity of pneumothorax following ENB and nodule size was performed using Pearson’s correlation analysis. The analyses were performed using SPSS Version 11.0 software for Windows (SPSS, Inc., Chicago, IL, USA). P < 0.05 (two-sided) was considered to indicate a statistically significant difference.

Results

CT-guided PTNB: Biopsy of lesion in lung parenchyma mapped on CT images

In last 20 years, the overall sensitivity, specificity, and accuracy of CT-guided PTNB were 92.52 ± 3.14%, 97.98 ± 3.28%, and 92.28% ± 5.40%, respectively. The top two complications of CT-guided PTNB were pneumothorax (1111/4822:23.04%) and hemorrhage (287/3503:8.19%), respectively. Two cases with severe complications were reported [2, 3]. Bronchial artery embolization was performed in one patient due to massive hemoptysis [3]. The other one suffered from cardiopulmonary arrest leading to death [2].

Diagnostic accuracy and incidence of complications seemed to be decreased [3,4,5] and increased [2,3,4,5,6,7,8,9], respectively, by smaller lesion size or longer needle path length (P < 0.05).

ENB: Biopsy of lesion in lung parenchyma and mediastinal area

The detection rate of lung cancer by ENB increased gradually (Fig. 1a) and was recently reported to be 96.8% [10]. There seemed to be no significant correlation between detection rate and number of cases, average age of patients, sex, nodule size, lobar location of nodule, mean distance from pleura to nodule and operation time. As shown in Fig. 1b, pneumothorax was the top one complication following ENB (86/1648:5.2%). In 86 pneumothorax cases, 34 cases (34/86) were administrated with closed drainage [10,11,12,13,14,15,16,17,18,19,20,21], and one case (1/86) was managed with manual aspiration and observation [19]. The other 51 cases with mild pneumothorax were discharged for rehabilitation. Intriguingly, the incidence of pneumothorax was significantly negatively correlated with nodule size (R = − 0.512, P = 0.018, Fig. 1c). The three hemorrhage cases were observed carefully without further intervention and were discharged for rehabilitation [16, 22]. Three cases of respiratory failure were reported without detailed depiction [16]. There were no ENB related death [10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26,27,28,29,30]. ENB plus EBUS imaging seemed to yield a higher detection rate as compared with sole use of ENB (59% vs. 88% [20] and 71.42% vs. 73.07% [11]). Surprisingly, studies combining fluoroscopy with ENB to confirm navigation success reported lower diagnostic yields (56.3 vs. 69.2% without fluoroscopy, p = 0.006) [31].

Fig. 1
figure 1

Analysis of clinical points regarding ENB. a Correlation between detection rate and publication time showing the detection rate increased gradually. b Pneumothorax was the top one complication following ENB (86/1648:5.2%). c The morbidity of pneumothorax was significantly negatively correlated with nodule size (R = −0.512, P = 0.018)

Full size image

EBUS-TBNA: Biopsy of lesion in subcarinal and bilateral hilar area

The detection rate of lung node by EBUS-TBNA remained to be 86.06 ± 9.70%. The diagnostic sensitivity, specificity, accuracy, positive predictive value and negative predictive value of EBUS-TBNA for the mediastinal staging of lung cancer were 85.48% ± 12.89%, 99.09% ± 3.15%, 92.88% ± 4.99%, 98.70% ± 3.03%, 83.03% ± 15.46%, respectively. As shown in Fig. 2a, the top three complications following EBUS-TBNA were hemorrhage (53/8662:0.61%), pneumothorax (46/12432:0.37%) and infection (34/11250:0.30%), respectively. Four hemorrhage cases were administrated with further intervention with one perioperative death. The other 49 cases with mild hemorrhage were discharged for rehabilitation [32, 33]. In 46 pneumothorax cases, nine cases (9/46) and 37 cases (37/46) were administrated with closed drainage and conservative treatment, respectively [32,33,34,35]. Perioperative mortality was relatively low (4/11189:0.04%). Besides the above mentioned one case died of severe hemorrhage, there was one case died of cerebral infarction and two unexplained deaths [32, 33, 36].

Fig. 2
figure 2

Analysis of clinical points regarding EBUS-TBNA and mediastinoscopy. a The top three complications following EBUS-TBNA were hemorrhage (53/8662:0.61%), pneumothorax (46/12432:0.37%) and infection (34/11250:0.30%), respectively. b The detection rate by using mediastinoscopy increased slightly. c The positive rate of 4thR (91.5% ± 9.35%) and 7th (80.56% ± 19.47%) lymph node by using mediastinoscopy were significantly higher than others (P < 0.05). d Hoarseness (67/4387:1.53%) was the top one complication following mediastinoscopy

Full size image

Mediastinoscopy: Biopsy of the lesion or lymph node in the vicinity of the trachea, the subcarinal and the bronchi area

The detection rate of lung cancer by mediastinoscopy increased slightly (Fig. 2b) which was reported to be 96% in recent years [37]. The diagnostic sensitivity, specificity, accuracy, positive predictive value and negative predictive value of mediastinoscopy for the mediastinal staging of lung cancer were 82.83% ± 10.63%, 100%, 93.98% ± 4.68%, 100%, 87.64% ± 13.00%, respectively. Intriguingly, the positive rates of 4thR (91.5% ± 9.35%) and 7th (80.56% ± 19.47%) lymph node were significantly higher than others (P = 0.03) (Fig. 2c). As shown in Fig. 2d, hoarseness (67/4387:1.53%) was the top one complication following mediastinoscopy. Among the abovementioned 67 cases with hoarseness, nine cases (9/67) suffered from permanent hoarseness, two cases (2/67) recovered partially by vocal cord medialization and six cases (6/67) recovered within a few months [37,38,39,40,41,42,43,44,45]. Perioperative mortality was relatively low (4/2137: 0.19%). The death causes among three cases were aortic laceration, stroke, and cardiac arrest, respectively, and one case die of unexplained cause [46].

CTC: Biopsies of tumor cells shed from solid tumor lesion into peripheral blood

The mean sensitivities of a variety of methods to detect CTC remained to be 63.05%. As shown in Fig. 3a, sensitivity of PCR seemed to be highest (78.81 ± 14.72%). Sensitivity of Density-gradient, ISET and Magnetic bead seemed to be higher than 60% (71.32% ± 2.8%, 67.75% ± 21.22% and 67.85% ± 25.24%, respectively). Specificity of ISET, PCR and Cell search was relatively high (100%, 90.88 ± 0.53% and 94.33% ± 9.82%, respectively). There was no published data regarding specificity of Magnetic bead and density-gradient.

Fig. 3
figure 3

Analysis of clinical points regarding CTCs. a Sensitivity of PCR seemed to be highest (78.81 ± 14.72%). Specificity of ISET, PCR and Cell search was relatively high (100%, 90.88 ± 0.53% and 94.33 ± 9.82%). b Sensitivity of Multimarker assay seemed to be highest(90%) including 17 target genes: AGR2, CEACAM5, MMP11, STRN3, CEACAM6, COL5A2, AMPH, CEACAM7, ABCC3, THY1, COL6A3, ENO1, PNN, SCFD1, KDELR3, KIAA0391, TACSTD1

Full size image

Intriguingly, there are a variety of biomarker combination for CTCs identification by using PCR yielding different sensitivities. As shown in Fig. 3b, the sensitivity of Multimarker assay seemed to be highest (90%). Besides, the sensitivity of the combination of TSA-9, KRT-19, Pre-proGRP was satisfactory (84.3%).

Discussion

Considering the exquisite anatomy of the mediastinum, hilar and lung parenchyma, the equipment and technique, e.g., percutaneous lung biopsy, ENB, EBUS-TBNA, and Mediastinoscopy developed quickly. Furthermore, liquid biopsy, e.g., CTC detection has been introduced and a few pilot studies regarding early diagnosis of lung cancer have been published [47,48,49,50,51,52,53,54,55,56,57,58,59,60,61,62,63,64,65]. According to application in specific location and situation, we systemic reviewed clinical updates of these approaches focusing on development trends, detection rate and complications .

CT-guided PTNB is regarded as an effective and feasible procedure to detect a difficult nodule with advantage of accurate positioning and high detection accuracy. Nevertheless, once the lesion diameter is less than 2 cm or the needle path length is more than 8 cm, the detection rate will drop dramatically [4]. In addition, the lesions in the vicinity of mediastinum vessels are challengers to clinicians with regards to safety. Currently, ENB is developed for biopsy of the lesions in deep lung parenchyma or mediastinum.

ENB is recommended in patients with lesions in lung parenchyma difficult to reach with conventional bronchoscopy or CT-guided PTNB. The detection rate of ENB increased gradually probably due to improvement of software and hardware. Eberhardt et al. [20] found nodule location has been noted to be an important factor in diagnostic yield, e.g., the yields from the lower lobes were significantly lower (29%; p = 0.01). However, Jensen et al. [22] found lobar location of nodule did not affect the diagnostic yield (p = 0.59). Therefore, we systematically analyzed the results of six studies mentioning detection rate and nodule location [14, 20, 22, 27, 29, 66], and found that there seemed to be no association between them (p = 0.433). The highest incidence of complication is pneumothorax (5.2%). However, pneumothorax following ENB was reported to be unrelated with age or sex [16], accordant with our results. Intriguingly, the incidence of pneumothorax seemed to be significantly negatively correlated with nodule size, probably due to difficulties varying with the size. Additionally, there was no reported ENB associated death, proving that ENB is relatively safe.

Empirically, EBUS-TBNA is suitable for biopsy of lesion in subcarinal and bilateral hilar area. EBUS-TBNA is also well utilized in the peripheral area with radial probe EBUS and in conjunction with ENB. As EBUS-TBNA has relatively high false negative rates, especially at station 4R or 7 lymph node, mediastinoscopy is still required for patients with suspicious nodal disease in these stations [67]. Cytological samples are usually taken by EBUS-TBNA, however, larger histological tissue samples are possible to obtain by mediastinoscopy.

Mediastinoscopy is always recognized as the gold standard for surgical staging of lung cancer which is suitable for biopsy in the vicinity of the trachea, the subcarinal and the bronchi area. Especially, the positive rate of station 4Rth (91.5 ± 9.35%) and 7th (80.56 ± 19.47%) lymph node were significantly higher than other stations (Fig. 2c). Nevertheless, as mediastinoscopy is an invasive approach, the incidences of complications are relatively remarkable.

CTC is a kind of liquid biopsies of tumor cells shed from solid tumor lesions (primary foci and metastases) into peripheral blood. Although the mean sensitivities of CTC detection were not satisfactory, the convenience of this non-invasive method seems to be incomparable. Sensitivity of PCR remained to be highest (78.81% ± 14.72%) as compared with other methods. Intriguingly, the sensitivities of PCR varies with combined biomarkers. Expectedly, the sensitivity of combination of multimarkers assay is highest (90%). Furthermore, the specificity of the three methods, i.e., ISET, PCR and Cell search, was relatively high (100%, 90.88% ± 0.53% and 94.33% ± 9.82%, respectively). Currently, CTC can be used as an auxiliary diagnostic method to provide a higher detection rate.

Conclusions

The biopsy approaches should be chosen according to a variety of location and situation of lesions. CT-guided PTNB is regarded as an effective and feasible procedure for biopsy in lung parenchyma, however, diagnostic accuracy and incidence of complications may be impacted by lesion size or needle path length. ENB has an advantage for biopsy of smaller and deeper lesions in lung parenchyma. ENB plus EBUS imaging can further improve the detection rate. EBUS-TBNA and mediastinoscopy can be recommended for the biopsy in lower and upper mediastinum, respectively. The former is relatively safer and the latter provides more tissue acquisition and better diagnostic yield of 4R and 7th lymph node. CTC detection can be considered for adjuvant diagnosis.

Abbreviations

CTC:

Circulating tumor cell

EBUS-TBNA:

Endobroncheal Ultrasonography-Transbronchial Needle Aspitation

ENB:

Electromagnetic navigation bronchoscopy

PCR:

Polymerase chain reaction

PTNB:

Percutaneous transthoracic needle biopsy

References

  1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68(1):7–30.

    Article  PubMed  Google Scholar 

  2. Geraghty PR, et al. CT-guided transthoracic needle aspiration biopsy of pulmonary nodules: needle size and pneumothorax rate. Radiology. 2003;229(2):475–81.

    Article  PubMed  Google Scholar 

  3. Lee SM, et al. C-arm cone-beam CT-guided percutaneous transthoracic needle biopsy of lung nodules: clinical experience in 1108 patients. Radiology. 2014;271(1):291–300.

    Article  PubMed  Google Scholar 

  4. Ohno Y, et al. Transthoracic CT-guided biopsy with multiplanar reconstruction image improves diagnostic accuracy of solitary pulmonary nodules. Eur J Radiol. 2004;51(2):160–8.

    Article  PubMed  Google Scholar 

  5. Yang W, et al. Diagnostic accuracy of CT-guided transthoracic needle biopsy for solitary pulmonary nodules. PLoS One. 2015;10(6):e0131373.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  6. Gorgulu FF, et al. Computed tomography-guided transthoracic biopsy: factors influencing diagnostic and complication rates. J Int Med Res. 2017;45(2):808–15.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Otto S, et al. Predictors of technical success and rate of complications of image-guided percutaneous transthoracic lung needle biopsy of pulmonary tumors. PLoS One. 2015;10(4):e0124947.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  8. Sachdeva M, et al. Complications and yield of computed tomography-guided transthoracic Core needle biopsy of lung nodules at a high-volume academic Center in an Endemic Coccidioidomycosis Area. Lung. 2016;194(3):379–85.

    Article  PubMed  Google Scholar 

  9. Jaconi M, et al. C-arm cone-beam CT-guided transthoracic lung core needle biopsy as a standard diagnostic tool: an observational study. Medicine (Baltimore). 2015;94(12):e698.

    Article  Google Scholar 

  10. Mukherjee S, Chacey M. Diagnostic yield of electromagnetic navigation bronchoscopy using a curved-tip catheter to aid in the diagnosis of pulmonary lesions. J Bronchology Interv Pulmonol. 2017;24(1):35–9.

    Article  PubMed  Google Scholar 

  11. Ozgul G, et al. Efficacy and safety of electromagnetic navigation bronchoscopy with or without radial endobronchial ultrasound for peripheral lung lesions. Endosc Ultrasound. 2016;5(3):189–95.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Mahajan AK, et al. Electromagnetic navigational bronchoscopy: an effective and safe approach to diagnose peripheral lung lesions unreachable by conventional bronchoscopy in high-risk patients. J Bronchology Interv Pulmonol. 2011;18(2):133–7.

    Article  PubMed  Google Scholar 

  13. Schroeder C, Hejal R, Linden PA. Coil spring fiducial markers placed safely using navigation bronchoscopy in inoperable patients allows accurate delivery of CyberKnife stereotactic radiosurgery. J Thorac Cardiovasc Surg. 2010;140(5):1137–42.

    Article  PubMed  Google Scholar 

  14. Eberhardt R, et al. Electromagnetic navigation diagnostic bronchoscopy in peripheral lung lesions. Chest. 2007;131(6):1800–5.

    Article  PubMed  Google Scholar 

  15. Pearlstein DP, et al. Electromagnetic navigation bronchoscopy performed by thoracic surgeons: one center’s early success. Ann Thorac Surg. 2012;93(3):944–9. discussion 949-50

    Article  PubMed  Google Scholar 

  16. Towe CW, et al. Severe chronic obstructive pulmonary disease is not associated with complications after navigational bronchoscopy procedures. Ann Thorac Surg. 2017;104(1):290–5.

    Article  PubMed  Google Scholar 

  17. Makris D, et al. Electromagnetic navigation diagnostic bronchoscopy for small peripheral lung lesions. Eur Respir J. 2007;29(6):1187–92.

    Article  PubMed  CAS  Google Scholar 

  18. Bertoletti L, et al. Accuracy and feasibility of electromagnetic navigated bronchoscopy under nitrous oxide sedation for pulmonary peripheral opacities: an outpatient study. Respiration. 2009;78(3):293–300.

    Article  PubMed  Google Scholar 

  19. Chee A, et al. Diagnostic utility of peripheral endobronchial ultrasound with electromagnetic navigation bronchoscopy in peripheral lung nodules. Respirology. 2013;18(5):784–9.

    Article  PubMed  Google Scholar 

  20. Eberhardt R, et al. Multimodality bronchoscopic diagnosis of peripheral lung lesions: a randomized controlled trial. Am J Respir Crit Care Med. 2007;176(1):36–41.

    Article  PubMed  Google Scholar 

  21. Bowling MR, et al. The effect of general anesthesia versus intravenous sedation on diagnostic yield and success in electromagnetic navigation bronchoscopy. J Bronchology Interv Pulmonol. 2015;22(1):5–13.

    Article  PubMed  Google Scholar 

  22. Jensen KW, et al. Multicenter experience with electromagnetic navigation bronchoscopy for the diagnosis of pulmonary nodules. J Bronchology Interv Pulmonol. 2012;19(3):195–9.

    Article  PubMed  Google Scholar 

  23. Eberhardt R, et al. Comparison of suction catheter versus forceps biopsy for sampling of solitary pulmonary nodules guided by electromagnetic navigational bronchoscopy. Respiration. 2010;79(1):54–60.

    Article  PubMed  Google Scholar 

  24. Dale CR, et al. Navigational bronchoscopy with biopsy versus computed tomography-guided biopsy for the diagnosis of a solitary pulmonary nodule: a cost-consequences analysis. J Bronchology Interv Pulmonol. 2012;19(4):294–303.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Nabavizadeh N, et al. Electromagnetic navigational bronchoscopy-guided fiducial markers for lung stereotactic body radiation therapy: analysis of safety, feasibility, and interfraction stability. J Bronchology Interv Pulmonol. 2014;21(2):123–30.

    Article  PubMed  Google Scholar 

  26. Eberhardt R, et al. LungPoint--a new approach to peripheral lesions. J Thorac Oncol. 2010;5(10):1559–63.

    Article  PubMed  Google Scholar 

  27. Al-Jaghbeer M, et al. Diagnostic yield of electromagnetic navigational bronchoscopy. Ther Adv Respir Dis. 2016;10(4):295–9.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Gildea TR, et al. Electromagnetic navigation diagnostic bronchoscopy: a prospective study. Am J Respir Crit Care Med. 2006;174(9):982–9.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Lamprecht B, et al. Electromagnetic navigation bronchoscopy (ENB): increasing diagnostic yield. Respir Med. 2012;106(5):710–5.

    Article  PubMed  CAS  Google Scholar 

  30. Karnak D, et al. Rapid on-site evaluation and low registration error enhance the success of electromagnetic navigation bronchoscopy. Ann Thorac Med. 2013;8(1):28–32.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Gex G, et al. Diagnostic yield and safety of electromagnetic navigation bronchoscopy for lung nodules: a systematic review and meta-analysis. Respiration. 2014;87(2):165–76.

    Article  PubMed  Google Scholar 

  32. Asano F, et al. Complications associated with endobronchial ultrasound-guided transbronchial needle aspiration: a nationwide survey by the Japan Society for Respiratory Endoscopy. Respir Res. 2013;14:50.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Eapen GA, et al. Complications, consequences, and practice patterns of endobronchial ultrasound-guided transbronchial needle aspiration: results of the AQuIRE registry. Chest. 2013;143(4):1044–53.

    Article  PubMed  Google Scholar 

  34. Hayama M, et al. Complications with endobronchial ultrasound with a guide sheath for the diagnosis of peripheral pulmonary lesions. Respiration. 2015;90(2):129–35.

    Article  PubMed  Google Scholar 

  35. Steinfort DP, et al. Pulmonologist-performed per-esophageal needle aspiration of parenchymal lung lesions using an EBUS bronchoscope: diagnostic utility and safety. J Bronchology Interv Pulmonol. 2017;24(2):117–24.

    Article  PubMed  Google Scholar 

  36. Chen CH, et al. Endobronchial ultrasound changed the world of lung Cancer patients: a 11-year institutional experience. PLoS One. 2015;10(11):e0142336.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  37. Sayar A, et al. The incidence of hoarseness after mediastinoscopy and outcome of video-assisted versus conventional mediastinoscopy in lung cancer staging. Acta Chir Belg. 2016;116(1):23–9.

    Article  PubMed  Google Scholar 

  38. Turna A, et al. Video-assisted mediastinoscopic lymphadenectomy is associated with better survival than mediastinoscopy in patients with resected non-small cell lung cancer. J Thorac Cardiovasc Surg. 2013;146(4):774–80.

    Article  PubMed  Google Scholar 

  39. Chauhan A, et al. Cervical mediastinoscopy: re-evaluation of an old technique in era of new imaging technology. Indian J Chest Dis Allied Sci. 2012;54(3):169–73.

    PubMed  CAS  Google Scholar 

  40. Lardinois D, et al. Postinduction video-mediastinoscopy is as accurate and safe as video-mediastinoscopy in patients without pretreatment for potentially operable non-small cell lung cancer. Ann Thorac Surg. 2003;75(4):1102–6.

    Article  PubMed  Google Scholar 

  41. Hujala KT, Sipila JI, Grenman R. Mediastinoscopy--its role and value today in the differential diagnosis of mediastinal pathology. Acta Oncol. 2001;40(1):79–82.

    Article  PubMed  CAS  Google Scholar 

  42. Puhakka HJ. Complications of mediastinoscopy. J Laryngol Otol. 1989;103(3):312–5.

    Article  PubMed  CAS  Google Scholar 

  43. Cho JH, et al. A comparative analysis of video-assisted mediastinoscopy and conventional mediastinoscopy. Ann Thorac Surg. 2011;92(3):1007–11.

    Article  PubMed  Google Scholar 

  44. Anraku M, et al. Video-assisted mediastinoscopy compared with conventional mediastinoscopy: are we doing better? Ann Thorac Surg. 2010;89(5):1577–81.

    Article  PubMed  Google Scholar 

  45. Leschber G, et al. Does video-mediastinoscopy improve the results of conventional mediastinoscopy? Eur J Cardiothorac Surg. 2008;33(2):289–93.

    Article  PubMed  Google Scholar 

  46. Hammoud ZT, et al. The current role of mediastinoscopy in the evaluation of thoracic disease. J Thorac Cardiovasc Surg. 1999;118(5):894–9.

    Article  PubMed  CAS  Google Scholar 

  47. Bayarri-Lara C, et al. Circulating tumor cells identify early recurrence in patients with non-small cell lung Cancer undergoing radical resection. PLoS One. 2016;11(2):e0148659.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  48. Sawabata N, et al. Perioperative circulating tumor cells in surgical patients with non-small cell lung cancer: does surgical manipulation dislodge cancer cells thus allowing them to pass into the peripheral blood? Surg Today. 2016;46(12):1402–9.

    Article  PubMed  Google Scholar 

  49. Zhang W, et al. Tumor-selective replication herpes simplex virus-based technology significantly improves clinical detection and prognostication of viable circulating tumor cells. Oncotarget. 2016;7(26):39768–83.

    PubMed  PubMed Central  Google Scholar 

  50. Chen X, et al. Combination of circulating tumor cells with serum carcinoembryonic antigen enhances clinical prediction of non-small cell lung cancer. PLoS One. 2015;10(5):e0126276.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  51. Fiorelli A, et al. Circulating tumor cells in diagnosing lung Cancer: clinical and morphologic analysis. Ann Thorac Surg. 2015;99(6):1899–905.

    Article  PubMed  Google Scholar 

  52. Nair VS, et al. An observational study of circulating tumor cells and (18)F-FDG PET uptake in patients with treatment-naive non-small cell lung cancer. PLoS One. 2013;8(7):e67733.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  53. Hofman V, et al. Preoperative circulating tumor cell detection using the isolation by size of epithelial tumor cell method for patients with lung cancer is a new prognostic biomarker. Clin Cancer Res. 2011;17(4):827–35.

    Article  PubMed  CAS  Google Scholar 

  54. Funaki S, et al. Novel approach for detection of isolated tumor cells in pulmonary vein using negative selection method: morphological classification and clinical implications. Eur J Cardiothorac Surg. 2011;40(2):322–7.

    PubMed  Google Scholar 

  55. Franco R, et al. CXCL12-binding receptors expression in non-small cell lung cancer relates to tumoral microvascular density and CXCR4 positive circulating tumoral cells in lung draining venous blood. Eur J Cardiothorac Surg. 2012;41(2):368–75.

    Article  PubMed  Google Scholar 

  56. Hofman V, et al. Detection of circulating tumor cells as a prognostic factor in patients undergoing radical surgery for non-small-cell lung carcinoma: comparison of the efficacy of the CellSearch Assay and the isolation by size of epithelial tumor cell method. Int J Cancer. 2011;129(7):1651–60.

    Article  PubMed  CAS  Google Scholar 

  57. Yoon SO, et al. TTF-1 mRNA-positive circulating tumor cells in the peripheral blood predict poor prognosis in surgically resected non-small cell lung cancer patients. Lung Cancer. 2011;71(2):209–16.

    Article  PubMed  Google Scholar 

  58. Tanaka F, et al. Circulating tumor cell as a diagnostic marker in primary lung cancer. Clin Cancer Res. 2009;15(22):6980–6.

    Article  PubMed  CAS  Google Scholar 

  59. Liu L, et al. Detection of circulating cancer cells in lung cancer patients with a panel of marker genes. Biochem Biophys Res Commun. 2008;372(4):756–60.

    Article  PubMed  CAS  Google Scholar 

  60. Yie SM, et al. Clinical significance of detecting survivin-expressing circulating cancer cells in patients with non-small cell lung cancer. Lung Cancer. 2009;63(2):284–90.

    Article  PubMed  Google Scholar 

  61. Sawabata N, et al. Circulating tumor cells in peripheral blood caused by surgical manipulation of non-small-cell lung cancer: pilot study using an immunocytology method. Gen Thorac Cardiovasc Surg. 2007;55(5):189–92.

    Article  PubMed  Google Scholar 

  62. Sheu CC, et al. Development of a membrane array-based multimarker assay for detection of circulating cancer cells in patients with non-small cell lung cancer. Int J Cancer. 2006;119(6):1419–26.

    Article  PubMed  CAS  Google Scholar 

  63. Rolle A, et al. Increase in number of circulating disseminated epithelial cells after surgery for non-small cell lung cancer monitored by MAINTRAC(R) is a predictor for relapse: a preliminary report. World J Surg Oncol. 2005;3(1):18.

    Article  PubMed  PubMed Central  Google Scholar 

  64. Yamashita J, et al. Preoperative evidence of circulating tumor cells by means of reverse transcriptase-polymerase chain reaction for carcinoembryonic antigen messenger RNA is an independent predictor of survival in non-small cell lung cancer: a prospective study. J Thorac Cardiovasc Surg. 2002;124(2):299–305.

    Article  PubMed  CAS  Google Scholar 

  65. Yamashita JI, et al. Detection of circulating tumor cells in patients with non-small cell lung cancer undergoing lobectomy by video-assisted thoracic surgery: a potential hazard for intraoperative hematogenous tumor cell dissemination. J Thorac Cardiovasc Surg. 2000;119(5):899–905.

    Article  PubMed  CAS  Google Scholar 

  66. Brownback KR, et al. Electromagnetic navigational bronchoscopy in the diagnosis of lung lesions. J Bronchology Interv Pulmonol. 2012;19(2):91–7.

    Article  PubMed  Google Scholar 

  67. Cerfolio RJ, et al. The true false negative rates of esophageal and endobronchial ultrasound in the staging of mediastinal lymph nodes in patients with non-small cell lung cancer. Ann Thorac Surg. 2010;90(2):427–34.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

We’d appreciated Drs. Mingzhou Guo, Riitta Kaarteenaho and J. Francis Turner for valuable comments which improves our manuscript greatly.

Funding

This study was supported by grants from the National Natural Science Foundations of China (NSFC) (No. 81101782 and 81572285), and National Natural Science Foundation of Chongqing City (No.cstc2018jcyjAX0592).

Availability of data and materials

The dataset was searched on PubMed (http://www.ncbi.nlm.nih.gov). The search strategies and yielded citations were shown in Tables 1 and 2, respectively.

Author information

Author notes

  1. Chuan-Jiang Deng and Fu-Qiang Dai contributed equally to this work.

Authors and Affiliations

  1. Department of Thoracic Surgery, Institute of Surgery Research, Daping Hospital, Army Medical University, Chongqing, 400042, People’s Republic of China

    Chuan-Jiang Deng, Fu-Qiang Dai, Kai Qian, Qun-You Tan, Ru-Wen Wang, Bo Deng & Jing-Hai Zhou

Authors
  1. Chuan-Jiang Deng
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Fu-Qiang Dai
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kai Qian
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Qun-You Tan
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ru-Wen Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Bo Deng
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Jing-Hai Zhou
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

BD conceived and designed the study. CJD and FQD searched the data and performed data analysis. CJD wrote the paper. BD, JHZ, KQ, QYT and RWW reviewed and edited the manuscript. All authors read and approved the manuscript.

Corresponding authors

Correspondence to Bo Deng or Jing-Hai Zhou.

Ethics declarations

Ethics approval and consent to participate

Not applicable

Consent for publication

Not applicable

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Deng, CJ., Dai, FQ., Qian, K. et al. Clinical updates of approaches for biopsy of pulmonary lesions based on systematic review. BMC Pulm Med 18, 146 (2018). https://doi.org/10.1186/s12890-018-0713-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12890-018-0713-6

Keywords

BMC Pulmonary Medicine

ISSN: 1471-2466

Contact us